Processa Pharmaceuticals Inc.

01/26/2022 | Press release | Distributed by Public on 01/26/2022 07:16

Processa Pharmaceuticals CEO Dr. David Young Issues Letter to Shareholders Providing Outlook for 2022 - Form 8-K